Cetera Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-171,428
| Closed | -$2.59M | – | 3790 |
|
|
2024
Q3 | $2.59M | Buy |
171,428
+15,044
| +10% | +$227K | 0.01% | 1427 |
|
|
2024
Q2 | $2.22M | Buy |
156,384
+10,137
| +7% | +$144K | 0.01% | 1486 |
|
|
2024
Q1 | $1.99M | Buy |
146,247
+10,979
| +8% | +$150K | ﹤0.01% | 1546 |
|
|
2023
Q4 | $1.82M | Buy |
135,268
+18,268
| +16% | +$246K | 0.01% | 836 |
|
|
2023
Q3 | $1.46M | Buy |
117,000
+11,107
| +10% | +$139K | 0.01% | 882 |
|
|
2023
Q2 | $1.43M | Buy |
105,893
+13,093
| +14% | +$177K | 0.01% | 918 |
|
|
2023
Q1 | $1.29M | Buy |
92,800
+13,123
| +16% | +$183K | 0.01% | 924 |
|
|
2022
Q4 | $1.13M | Buy |
79,677
+13,915
| +21% | +$198K | 0.01% | 942 |
|
|
2022
Q3 | $898K | Buy |
65,762
+6,907
| +12% | +$94.3K | 0.02% | 765 |
|
|
2022
Q2 | $838K | Buy |
58,855
+11,527
| +24% | +$164K | 0.01% | 865 |
|
|
2022
Q1 | $783K | Sell |
47,328
-630
| -1% | -$10.4K | 0.01% | 906 |
|
|
2021
Q4 | $922K | Sell |
47,958
-71,259
| -60% | -$1.37M | 0.01% | 839 |
|
|
2021
Q3 | $2.48M | Sell |
119,217
-15,960
| -12% | -$332K | 0.04% | 448 |
|
|
2021
Q2 | $2.9M | Buy |
135,177
+3,623
| +3% | +$77.7K | 0.05% | 410 |
|
|
2021
Q1 | $2.59M | Buy |
131,554
+35,957
| +38% | +$709K | 0.05% | 362 |
|
|
2020
Q4 | $1.89M | Buy |
+95,597
| New | +$1.89M | 0.04% | 446 |
|